✦ LIBER ✦

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

✍ Scribed by Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Anthony Greco; David Spigel; Jeff Infante; Howard A. Burris III

Book ID: 115076688
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 124 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2008.n.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-551 A phase II randomized trial of wee

P-551 A phase II randomized trial of weekly versus. 3-weekly docetaxel as second line treatment for non-small cell lung cancer

✍ Tsai, Chun-Ming; Chiu, Chao-Hua; Wang, Gwo-Shu; Su, Wei-Juin; Chen, Yuh-Min; Per 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Phase II trial of weekly docetaxel (D) i

Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

P-576 Phase II trial of weekly topotecan

P-576 Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer

✍ Greco, F. Anthony; Burris, Howard A.; Yardley, Denise Aysel; Hainsworth, John Da 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Phase III trial comparing paclitaxel pol

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Randomized Phase II Trial of Concurrent

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

✍ Primo N. Lara Jr; Jeff Longmate; Karen Reckamp; Barbara Gitlitz; Athanassios Arg 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB